DeDora Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
APM
DeDora Capital's ARKG Position: Q2 2022 in Review
DeDora Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 50 shares — an estimated $2K sold.
DeDora Capital first reported a position in ARKG in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.
- DeDora Capital reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
- DeDora Capital sold 50 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $2K.
- DeDora Capital first reported a position in ARK Genomic Revolution ETF in Q1 2022 and held it in 1 quarter.
- DeDora Capital's ARK Genomic Revolution ETF position peaked at $2K in Q1 2022.
- 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.
Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.